Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Katarzyna Pogoda

Assistant Professor

Maria Sklodowska-Curie National Research Institute of Oncology

Poland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Poland

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (12)

Anna Borowiec

assistant professor

Medical University of Warsaw

POLAND

View details

Agata Bąk

assistant professor, PhD

University of Warsaw

POLAND

View details

Renata Duchnowska

Prof

Wojskowy Instytut Medyczny

POLAND

View details

Bela Mrinakova

Deputy of the Head of the Department

Comenius University in Bratislava

SLOVAKIA

View details

Kate Absolom

Associate Professor of Applied Health Research

University of Leeds

UNITED KINGDOM

View details

Yared Belete Belay

Monash University School of Public Health and Preventive Medicine

AUSTRALIA

View details

Elisa Agostinetto

Institut Jules Bordet

BELGIUM

View details

Leonor Vasconcelos Matos

Champalimaud Foundation

PORTUGAL

View details

BARBARA RADECKA

Head of Dept

Opole University

POLAND

View details

Hee Jeong Kim

University of Ulsan College of Medicine

SOUTH KOREA

View details

Anne Lanceley

University College London

UNITED KINGDOM

View details

Anne-Sophie HAMY

Institut Curie

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katarzyna Pogoda

Research Interests

Make your next move.

Explore related searches

Articles (20)

Assessing quality of life in individuals with hereditary cancer risk: Results from phases 1-3a of the EORTC QLQ-HCR30 questionnaire

Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancer

Which quality of life issues are important to patients with metastatic breast cancer: Phase 1 and 2 development of European Organisation for Research and Treatment of Cancer metastatic breast cancer module (EORTC QLQ-MBR)

Choosing Between Anti-TROP2 ADCs in Advanced Breast Cancer Without Head-to-Head Evidence: A Practical Evidence-Informed Decision Framework Endorsed by the Polish Society of Clinical Oncology

Clinical Decision-Making After Receptor Conversion Following Neoadjuvant Therapy in Breast Cancer: A Three-Strategy Framework

Current approaches to comprehensive oral care after cancer therapy

De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world study

Neurokinin pathway antagonists for vasomotor symptoms in women with breast cancer: focus on elinzanetant and fezolinetant

Dynamics of HER2 status following neoadjuvant systemic therapy in breast cancer: a large single-center cohort analysis

Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study

Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review

Real-world outcomes with palbociclib, ribociclib, and abemaciclib plus endocrine therapy in HR+/HER2− advanced breast cancer: A multicenter retrospective study

Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy

Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status

An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42

Antibody-Based Therapeutics in Breast Cancer: Clinical and Translational Perspectives

Management Strategies and Outcomes in HR+/HER2− Metastatic Breast Cancer Receiving CDK4/6 Inhibitors and Subsequent Therapies

Neurofilaments as Prognostic Biomarkers in the Assessment of the Risk of Advanced Taxane-Induced Neuropathy in Breast Cancer Patients—A Pilot Study

ASSESSING CLINICAL FEATURES AND OUTCOME OF BREAST CANCER IN PALB2 MUTATION CARRIERS: AN EUROPEAN MULTICENTRIC RETROSPECTIVE HOSPITAL-BASED COHORT CONTROL STUDY (PALBREAST)

Adaptation of the EORTC Quality of Life Breast Cancer Module for male Breast Cancer - Results of the Phase I-II module

Collaborators (12)

Anna Borowiec

Agata Bąk

Renata Duchnowska

Bela Mrinakova

Kate Absolom

Yared Belete Belay

Elisa Agostinetto

Leonor Vasconcelos Matos

BARBARA RADECKA

Hee Jeong Kim

Anne Lanceley

Anne-Sophie HAMY

Make your next move.